Related references
Note: Only part of the references are listed.Real-life effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
G. Brusselle et al.
RESPIRATORY MEDICINE (2009)
Healthcare and workloss costs associated with patients with persistent asthma in a privately insured population
G. Collice et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2006)
Omalizumab for asthma
RC Strunk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
W Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Share Paper
